{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:20:35Z","timestamp":1781590835627,"version":"3.54.5"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["25JRRA556"],"award-info":[{"award-number":["25JRRA556"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160146"],"award-info":[{"award-number":["82160146"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["25JRRA584"],"award-info":[{"award-number":["25JRRA584"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cellsig.2025.112310","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T17:04:57Z","timestamp":1765818297000},"page":"112310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Redox guardian or oncogenic driver? The dual roles of PRDX1 in tumorigenesis"],"prefix":"10.1016","volume":"139","author":[{"given":"Li","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-di","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-chun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cellsig.2025.112310_bb0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrm3801","article-title":"Cellular mechanisms and physiological consequences of redox-dependent signalling","volume":"15","author":"Holmstr\u00f6m","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"15","key":"10.1016\/j.cellsig.2025.112310_bb0010","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1128\/MCB.25.15.6391-6403.2005","article-title":"Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth","volume":"25","author":"Giannoni","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112310_bb0015","article-title":"Oxidative stress and antioxidant defense in endometriosis and its malignant transformation","volume":"2015","author":"Iwabuchi","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"11","key":"10.1016\/j.cellsig.2025.112310_bb0020","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1089\/ars.2011.4414","article-title":"Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy","volume":"16","author":"Gupta","year":"2012","journal-title":"Antioxid. Redox Signal."},{"issue":"5619","key":"10.1016\/j.cellsig.2025.112310_bb0025","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1126\/science.1080405","article-title":"Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling","volume":"300","author":"Wood","year":"2003","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112310_bb0030","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0968-0004(02)00003-8","article-title":"Structure, mechanism and regulation of peroxiredoxins","volume":"28","author":"Wood","year":"2003","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112310_bb0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/15216540252774748","article-title":"Peroxiredoxin, a novel family of peroxidases","volume":"52","author":"Rhee","year":"2001","journal-title":"IUBMB Life"},{"issue":"9","key":"10.1016\/j.cellsig.2025.112310_bb0040","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1111\/j.1742-4658.2009.06985.x","article-title":"Typical 2-Cys peroxiredoxins\u2013structures, mechanisms and functions","volume":"276","author":"Hall","year":"2009","journal-title":"FEBS J."},{"issue":"24","key":"10.1016\/j.cellsig.2025.112310_bb0045","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.4161\/cc.8.24.10242","article-title":"Peroxiredoxin 1 and its role in cell signaling","volume":"8","author":"Neumann","year":"2009","journal-title":"Cell Cycle"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112310_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108347","article-title":"PRDX1 counteracts catastrophic telomeric cleavage events that are triggered by DNA repair activities post oxidative damage","volume":"33","author":"Ahmed","year":"2020","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112310_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/cimm.1993.1043","article-title":"Identification of a natural killer enhancing factor (NKEF) from human erythroid cells","volume":"147","author":"Shau","year":"1993","journal-title":"Cell. Immunol."},{"issue":"45","key":"10.1016\/j.cellsig.2025.112310_bb0060","doi-asserted-by":"crossref","first-page":"43175","DOI":"10.1074\/jbc.M206066200","article-title":"Pag, a putative tumor suppressor, interacts with the Myc Box II domain of c-Myc and selectively alters its biological function and target gene expression","volume":"277","author":"Mu","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.cellsig.2025.112310_bb0065","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1101\/gad.11.19.2456","article-title":"The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity","volume":"11","author":"Wen","year":"1997","journal-title":"Genes Dev."},{"issue":"18","key":"10.1016\/j.cellsig.2025.112310_bb0070","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112310_bb0075","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/bcr3691","article-title":"Peroxiredoxin-1 protects estrogen receptor \u03b1 from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer","volume":"16","author":"O\u2019Leary","year":"2014","journal-title":"Breast Cancer Res."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112310_bb0080","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.7150\/jca.37147","article-title":"Up-regulation of peroxiredoxin-1 promotes cell proliferation and metastasis and inhibits apoptosis in cervical cancer","volume":"11","author":"Lu","year":"2020","journal-title":"J. Cancer"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112310_bb0085","first-page":"445","article-title":"Expression of peroxiredoxin 1 and 4 promotes human lung cancer malignancy","volume":"4","author":"Jiang","year":"2014","journal-title":"Am. J. Cancer Res."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112310_bb0090","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1158\/0008-5472.CAN-10-3674","article-title":"Peroxiredoxin 1 controls prostate cancer growth through Toll-like receptor 4\u2013dependent regulation of tumor vasculature","volume":"71","author":"Riddell","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2025.112310_bb0095","doi-asserted-by":"crossref","first-page":"9123","DOI":"10.2147\/OTT.S252286","article-title":"PRDX1 is a tumor suppressor for nasopharyngeal carcinoma by inhibiting PI3K\/AKT\/TRAF1 signaling","author":"Xiao","year":"2020","journal-title":"Onco. Targets. Ther."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112310_bb0100","first-page":"867","article-title":"Tumor suppressor Prdx1 is a prognostic factor in esophageal squamous cell carcinoma patients","volume":"18","author":"Hoshino","year":"2007","journal-title":"Oncol. Rep."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112310_bb0105","first-page":"1922","article-title":"Peroxiredoxin1 promotes cell proliferation, migration and invasion of colorectal cancer via p38MAPK signaling","volume":"22","author":"Cong","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112310_bb0110","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41416-018-0263-y","article-title":"Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents","volume":"119","author":"Bajor","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cellsig.2025.112310_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101959","article-title":"Peroxiredoxins wear many hats: factors that fashion their peroxide sensing personalities","volume":"42","author":"Bolduc","year":"2021","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112310_bb0120","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/prot.22936","article-title":"Analysis of the peroxiredoxin family: using active-site structure and sequence information for global classification and residue analysis","volume":"79","author":"Nelson","year":"2011","journal-title":"Proteins"},{"issue":"8","key":"10.1016\/j.cellsig.2025.112310_bb0125","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/s41416-021-01510-x","article-title":"Peroxiredoxin-1 Tyr194 phosphorylation regulates LOX-dependent extracellular matrix remodelling in breast cancer","volume":"125","author":"Attaran","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"28","key":"10.1016\/j.cellsig.2025.112310_bb0130","doi-asserted-by":"crossref","first-page":"25370","DOI":"10.1074\/jbc.M110432200","article-title":"Regulation of peroxiredoxin I activity by Cdc2-mediated phosphorylation","volume":"277","author":"Chang","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112310_bb0135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3892\/mco.2017.1129","article-title":"The role of peroxiredoxins in cancer","volume":"6","author":"Nicolussi","year":"2017","journal-title":"Mol. Clin. Oncol."},{"issue":"31","key":"10.1016\/j.cellsig.2025.112310_bb0140","doi-asserted-by":"crossref","first-page":"28775","DOI":"10.1074\/jbc.M505362200","article-title":"Oxidative stress-dependent structural and functional switching of a human 2-Cys peroxiredoxin isotype II that enhances HeLa cell resistance to H2O2-induced cell death","volume":"280","author":"Moon","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112310_bb0145","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.str.2012.01.004","article-title":"Moonlighting by different stressors: crystal structure of the chaperone species of a 2-Cys peroxiredoxin","volume":"20","author":"Saccoccia","year":"2012","journal-title":"Structure"},{"issue":"38","key":"10.1016\/j.cellsig.2025.112310_bb0150","doi-asserted-by":"crossref","first-page":"29138","DOI":"10.1074\/jbc.M110.135905","article-title":"T-LAK cell-originated protein kinase (TOPK) phosphorylation of Prx1 at Ser-32 prevents UVB-induced apoptosis in RPMI7951 melanoma cells through the regulation of Prx1 peroxidase activity","volume":"285","author":"Zykova","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"47","key":"10.1016\/j.cellsig.2025.112310_bb0155","doi-asserted-by":"crossref","first-page":"15407","DOI":"10.1021\/bi992025k","article-title":"Protein-sulfenic acids: diverse roles for an unlikely player in enzyme catalysis and redox regulation","volume":"38","author":"Claiborne","year":"1999","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.cellsig.2025.112310_bb0160","doi-asserted-by":"crossref","DOI":"10.15252\/msb.202211267","article-title":"A metabolic map of the DNA damage response identifies PRDX1 in the control of nuclear ROS scavenging and aspartate availability","volume":"19","author":"Moretton","year":"2023","journal-title":"Mol. Syst. Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112310_bb0165","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.freeradbiomed.2006.11.005","article-title":"Selective protection of nuclear thioredoxin-1 and glutathione redox systems against oxidation during glucose and glutamine deficiency in human colonic epithelial cells","volume":"42","author":"Go","year":"2007","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112310_bb0170","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.freeradbiomed.2007.04.029","article-title":"Nuclear and cytoplasmic peroxiredoxin-1 differentially regulate NF-\u03baB activities","volume":"43","author":"Hansen","year":"2007","journal-title":"Free Rad. Biol. Med."},{"issue":"1\u20132","key":"10.1016\/j.cellsig.2025.112310_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2008.08.006","article-title":"Glutathione: overview of its protective roles, measurement, and biosynthesis","volume":"30","author":"Forman","year":"2009","journal-title":"Mol. Aspects Med."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112310_bb0180","first-page":"794","article-title":"Production of large amounts of hydrogen peroxide by human tumor cells","volume":"51","author":"Szatrowski","year":"1991","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112310_bb0185","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.febslet.2009.05.029","article-title":"The oligomeric conformation of peroxiredoxins links redox state to function","volume":"583","author":"Barranco-Medina","year":"2009","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112310_bb0190","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cell.2004.05.002","article-title":"Two enzymes in one: two yeast peroxiredoxins display oxidative stress-dependent switching from a peroxidase to a molecular chaperone function","volume":"117","author":"Jang","year":"2004","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cellsig.2025.112310_bb0195","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1677\/ERC-09-0269","article-title":"Suppression of MG132-mediated cell death by peroxiredoxin 1 through influence on ASK1 activation in human thyroid cancer cells","volume":"17","author":"Du","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"issue":"40","key":"10.1016\/j.cellsig.2025.112310_bb0200","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1038\/onc.2011.139","article-title":"Oligomeric peroxiredoxin-I is an essential intermediate for p53 to activate MST1 kinase and apoptosis","volume":"30","author":"Morinaka","year":"2011","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112310_bb0205","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1007\/s12032-013-0786-2","article-title":"Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma","volume":"31","author":"Sun","year":"2014","journal-title":"Med. Oncol."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112310_bb0210","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1158\/1078-0432.CCR-07-4457","article-title":"Up-regulation of peroxiredoxin 1 in lung cancer and its implication as a prognostic and therapeutic target","volume":"14","author":"Kim","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112310_bb0215","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41523-021-00374-x","article-title":"HBXIP induces anoikis resistance by forming a reciprocal feedback loop with Nrf2 to maintain redox homeostasis and stabilize Prdx1 in breast cancer","volume":"8","author":"Zhou","year":"2022","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112310_bb0220","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1021\/pr900811x","article-title":"Proteomic identification of overexpressed PRDX 1 and its clinical implications in ovarian carcinoma","volume":"9","author":"Chung","year":"2010","journal-title":"J. Proteome Res."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112310_bb0225","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ygyno.2011.02.031","article-title":"Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammation","volume":"121","author":"Maxwell","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112310_bb0230","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.bbamcr.2019.04.007","article-title":"Tumor protein D52 (isoform 3) interacts with and promotes peroxidase activity of Peroxiredoxin 1 in prostate cancer cells implicated in cell growth and migration","volume":"1866","author":"Dasari","year":"2019","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cellsig.2025.112310_bb0235","doi-asserted-by":"crossref","first-page":"1669822","DOI":"10.3389\/fimmu.2025.1669822","article-title":"Multi-omics dissection of fatty acid metabolism heterogeneity identifies PRDX1 as a prognostic marker in bladder cancer","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112310_bb0240","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1021\/pr8000892","article-title":"Proteomic expression analysis of surgical human colorectal cancer tissues: up-regulation of PSB7, PRDX1, and SRP9 and hypoxic adaptation in cancer","volume":"7","author":"Rho","year":"2008","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112310_bb0245","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s42003-020-01552-6","article-title":"Integrated molecular characterisation of the MAPK pathways in human cancers reveals pharmacologically vulnerable mutations and gene dependencies","volume":"4","author":"Sinkala","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.cellsig.2025.112310_bb0250","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ijbiomac.2018.02.009","article-title":"Prdx1 alleviates cardiomyocyte apoptosis through ROS-activated MAPK pathway during myocardial ischemia\/reperfusion injury","volume":"112","author":"Guo","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"45","key":"10.1016\/j.cellsig.2025.112310_bb0255","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1038\/onc.2012.624","article-title":"Role for Prdx1 as a specific sensor in redox-regulated senescence in breast cancer","volume":"32","author":"Turner-Ivey","year":"2013","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112310_bb0260","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41388-019-0991-3","article-title":"TXNDC9 regulates oxidative stress-induced androgen receptor signaling to promote prostate cancer progression","volume":"39","author":"Feng","year":"2020","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112310_bb0265","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41467-025-55939-2","article-title":"Inhibited peroxidase activity of peroxiredoxin 1 by palmitic acid exacerbates nonalcoholic steatohepatitis in male mice","volume":"16","author":"Yin","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2025.112310_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102443","article-title":"Redox regulation of RAD51 Cys319 and homologous recombination by peroxiredoxin 1","volume":"56","author":"Skoko","year":"2022","journal-title":"Redox Biol."},{"issue":"9\u201310","key":"10.1016\/j.cellsig.2025.112310_bb0275","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1101\/gad.313460.118","article-title":"PRDX1 and MTH1 cooperate to prevent ROS-mediated inhibition of telomerase","volume":"32","author":"Ahmed","year":"2018","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112310_bb0280","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41419-021-03557-3","article-title":"Cullin-5 neddylation-mediated NOXA degradation is enhanced by PRDX1 oligomers in colorectal cancer","volume":"12","author":"Xu","year":"2021","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112310_bb0285","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41419-023-05732-0","article-title":"Radiation induces IRAK1 expression to promote radioresistance by suppressing autophagic cell death via decreasing the ubiquitination of PRDX1 in glioma cells","volume":"14","author":"Li","year":"2023","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112310_bb0290","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3390\/antiox10040570","article-title":"Genetic inactivation of peroxiredoxin-I impairs the growth of human pancreatic cancer cells","volume":"10","author":"Dahou","year":"2021","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112310_bb0295","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s13046-019-1364-z","article-title":"LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus","volume":"38","author":"Jiang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.cellsig.2025.112310_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050394","article-title":"Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1\u03b1","volume":"7","author":"Riddell","year":"2012","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112310_bb0305","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejso.2014.11.037","article-title":"Expression and clinical value of peroxiredoxin-1 in patients with pancreatic cancer","volume":"41","author":"Cai","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.cellsig.2025.112310_bb0310","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ebiom.2019.01.045","article-title":"Tumor cells induce LAMP2a expression in tumor-associated macrophage for cancer progression","volume":"40","author":"Wang","year":"2019","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.cellsig.2025.112310_bb0315","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1089\/ars.2010.3393","article-title":"Multiple functions of peroxiredoxins: peroxidases, sensors and regulators of the intracellular messenger H2O2, and protein chaperones","volume":"15","author":"Rhee","year":"2011","journal-title":"Antioxid. Redox Signal."},{"issue":"6948","key":"10.1016\/j.cellsig.2025.112310_bb0320","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature01819","article-title":"Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression","volume":"424","author":"Neumann","year":"2003","journal-title":"Nature"},{"issue":"54","key":"10.1016\/j.cellsig.2025.112310_bb0325","doi-asserted-by":"crossref","first-page":"8038","DOI":"10.1038\/sj.onc.1208821","article-title":"Regulation of reactive oxygen species, DNA damage and c-Myc function by peroxiredoxin 1","volume":"24","author":"Egler","year":"2005","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.cellsig.2025.112310_bb0330","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/emboj.2009.101","article-title":"Prdx1 inhibits tumorigenesis via regulating PTEN\/AKT activity","volume":"28","author":"Cao","year":"2009","journal-title":"EMBO J."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112310_bb0335","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1080\/15548627.2018.1474995","article-title":"Inhibition of TRAF6 ubiquitin-ligase activity by PRDX1 leads to inhibition of NFKB activation and autophagy activation","volume":"14","author":"Min","year":"2018","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112310_bb0340","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1186\/s12885-019-6031-4","article-title":"The peroxidase PRDX1 inhibits the activated phenotype in mammary fibroblasts through regulating c-Jun N-terminal kinases","volume":"19","author":"Jezierska-Drutel","year":"2019","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.cellsig.2025.112310_bb0345","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.474","article-title":"Cancer-derived immunoglobulin G promotes tumor cell growth and proliferation through inducing production of reactive oxygen species","volume":"4","author":"Wang","year":"2013","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.cellsig.2025.112310_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114682","article-title":"MOF-mediated PRDX1 acetylation regulates inflammatory macrophage activation","volume":"43","author":"Chen","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.cellsig.2025.112310_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101789","article-title":"PRDX1 Cys52Ser variant alleviates nonalcoholic steatohepatitis by reducing inflammation in mice","volume":"76","author":"Bai","year":"2023","journal-title":"Mol. Metabol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112310_bb0360","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1186\/s12885-019-6046-x","article-title":"Expression of thioredoxin 1 and peroxiredoxins in squamous cervical carcinoma and its predictive role in NACT","volume":"19","author":"Zhu","year":"2019","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.cellsig.2025.112310_bb0365","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.oraloncology.2009.07.002","article-title":"Peroxiredoxin I plays a protective role against cisplatin cytotoxicity through mitogen activated kinase signals","volume":"45","author":"Ma","year":"2009","journal-title":"Oral Oncol."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112310_bb0370","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1080\/15548627.2021.1905466","article-title":"PRDX1 activates autophagy via the PTEN-AKT signaling pathway to protect against cisplatin-induced spiral ganglion neuron damage","volume":"17","author":"Liu","year":"2021","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112310_bb0375","doi-asserted-by":"crossref","first-page":"760","DOI":"10.7150\/ijbs.65258","article-title":"Underlying the mechanisms of doxorubicin-induced acute cardiotoxicity: oxidative stress and cell death","volume":"18","author":"Kong","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112310_bb0380","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3892\/ijo.2014.2398","article-title":"Peroxiredoxin proteins protect MCF-7 breast cancer cells from doxorubicin-induced toxicity","volume":"45","author":"McDonald","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cellsig.2025.112310_bb0385","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.2147\/OTT.S303152","article-title":"\u03b2-Elemene enhances the sensitivity of osteosarcoma cells to doxorubicin via downregulation of peroxiredoxin-1","author":"Zhang","year":"2021","journal-title":"Onco. Targets. Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112310_bb0390","first-page":"2405135","article-title":"Peroxiredoxin-1 overexpression attenuates doxorubicin-induced cardiotoxicity by inhibiting oxidative stress and cardiomyocyte apoptosis","volume":"2020","author":"Jiang","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112310_bb0395","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bcp.2014.02.022","article-title":"Adenanthin targets proteins involved in the regulation of disulphide bonds","volume":"89","author":"Muchowicz","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cellsig.2025.112310_bb0400","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.freeradbiomed.2014.09.025","article-title":"Interaction of adenanthin with glutathione and thiol enzymes: selectivity for thioredoxin reductase and inhibition of peroxiredoxin recycling","volume":"77","author":"Soethoudt","year":"2014","journal-title":"Free Rad. Biol. Med."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112310_bb0405","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nchembio.935","article-title":"Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells","volume":"8","author":"Liu","year":"2012","journal-title":"Nat. Chem. Biol."},{"issue":"9","key":"10.1016\/j.cellsig.2025.112310_bb0410","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.345","article-title":"Adenanthin targets peroxiredoxin I\/II to kill hepatocellular carcinoma cells","volume":"5","author":"Hou","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2025.112310_bb0415","series-title":"ROS, Redox Regulation, and Anticancer Therapy. Redox Regulation and Therapeutic Approaches in Cancer","first-page":"311","author":"Bansal","year":"2023"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112310_bb0420","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.543","article-title":"Celastrol induces apoptosis and autophagy via the ROS\/JNK signaling pathway in human osteosarcoma cells: an in vitro and in vivo study","volume":"6","author":"Li","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2025.112310_bb0425","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.canlet.2021.08.023","article-title":"Peroxiredoxin 1 is essential for natamycin-triggered apoptosis and protective autophagy in hepatocellular carcinoma","volume":"521","author":"An","year":"2021","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112310_bb0430","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.7150\/ijbs.78554","article-title":"Chemical-proteomics identify peroxiredoxin-1 as an actionable target in triple-negative breast cancer","volume":"19","author":"Sp\u00ednola-Lasso","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112310_bb0435","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.chembiol.2018.11.013","article-title":"Frenolicin B targets peroxiredoxin 1 and glutaredoxin 3 to trigger ROS\/4E-BP1-mediated antitumor effects","volume":"26","author":"Ye","year":"2019","journal-title":"Cell Chem. Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112310_bb0440","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.chembiol.2023.02.003","article-title":"Ainsliadimer A induces ROS-mediated apoptosis in colorectal cancer cells via directly targeting peroxiredoxin 1 and 2","volume":"30","author":"Lv","year":"2023","journal-title":"Cell Chem. Biol."},{"issue":"22","key":"10.1016\/j.cellsig.2025.112310_bb0445","doi-asserted-by":"crossref","first-page":"10290","DOI":"10.7150\/thno.46728","article-title":"Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112310_bb0450","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41392-022-01231-4","article-title":"Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1","volume":"8","author":"Xu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.cellsig.2025.112310_bb0455","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1021\/acs.jmedchem.4c00023","article-title":"Discovery of urea derivatives of celastrol as selective peroxiredoxin 1 inhibitors against colorectal cancer cells","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.cellsig.2025.112310_bb0460","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.3390\/nu14204219","article-title":"Vitamin K contribution to DNA damage\u2014advantage or disadvantage? A human health response","volume":"14","author":"Ka\u017amierczak-Bara\u0144ska","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112310_bb0465","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13046-015-0270-2","article-title":"PRX1 knockdown potentiates vitamin K3 toxicity in cancer cells: a potential new therapeutic perspective for an old drug","volume":"34","author":"He","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2025.112310_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115656","article-title":"Development of novel celastrol-ligustrazine hybrids as potent peroxiredoxin 1 inhibitors against lung cancer","volume":"259","author":"Bai","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cellsig.2025.112310_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.152457","article-title":"Rosmarinic acid confers beneficial effects by specifically activating PRDX1 peroxidase activity","author":"Shi","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112310_bb0480","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.chembiol.2021.09.003","article-title":"Screening compound libraries for H2O2-mediated cancer therapeutics using a peroxiredoxin-based sensor","volume":"29","author":"Hao","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.cellsig.2025.112310_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.102355","article-title":"The multifaceted nature of peroxiredoxins in chemical biology","volume":"76","author":"Villar","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112310_bb0490","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ygyno.2021.05.018","article-title":"Rationale for combination PARP inhibitor and antiangiogenic treatment in advanced epithelial ovarian cancer: a review","volume":"162","author":"Secord","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112310_bb0495","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12943-020-01227-0","article-title":"PARP inhibitor resistance: the underlying mechanisms and clinical implications","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112310_bb0500","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12967-021-02792-8","article-title":"Expression and prognostic roles of PRDXs gene family in hepatocellular carcinoma","volume":"19","author":"Xu","year":"2021","journal-title":"J. Transl. Med."},{"issue":"11","key":"10.1016\/j.cellsig.2025.112310_bb0505","first-page":"657","article-title":"PRDX1 influences the occurrence and progression of liver cancer by inhibiting mitochondrial apoptosis pathway","volume":"24","author":"Sun","year":"2022","journal-title":"Cell J. (Yakhteh)"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112310_bb0510","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13765-022-00732-8","article-title":"Regulatory effect of peroxiredoxin 1 (PRDX1) on doxorubicin-induced apoptosis in triple negative breast cancer cells","volume":"65","author":"Han","year":"2022","journal-title":"Appl. Biol. Chem."},{"key":"10.1016\/j.cellsig.2025.112310_bb0515","doi-asserted-by":"crossref","first-page":"7745","DOI":"10.2147\/OTT.S175009","article-title":"Decreased expression of peroxiredoxin1 inhibits proliferation, invasion, and metastasis of ovarian cancer cell","author":"Zheng","year":"2018","journal-title":"Onco. Targets. Ther."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112310_bb0520","doi-asserted-by":"crossref","first-page":"415","DOI":"10.26444\/aaem\/105899","article-title":"Peroxiredoxin-1 as a prognostic factor in patients with ovarian cancer","volume":"26","author":"Sie\u0144ko","year":"2019","journal-title":"Ann. Agric. Environ. Med."},{"key":"10.1016\/j.cellsig.2025.112310_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103392","article-title":"HJURP inhibits sensitivity to ferroptosis inducers in prostate cancer cells by enhancing the peroxidase activity of PRDX1","volume":"77","author":"Lai","year":"2024","journal-title":"Redox Biol."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112310_bb0530","doi-asserted-by":"crossref","first-page":"9829","DOI":"10.1007\/s13277-015-3758-7","article-title":"Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach","volume":"36","author":"Dey","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cellsig.2025.112310_bb0535","doi-asserted-by":"crossref","first-page":"10883","DOI":"10.2147\/CMAR.S235317","article-title":"Silencing of peroxiredoxin 1 inhibits the proliferation of esophageal cancer cells and promotes apoptosis by inhibiting the activity of the PI3K\/AKT pathway","author":"Song","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112310_bb0540","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12032-014-0455-0","article-title":"Peroxiredoxin 1 promotes tumorigenesis through regulating the activity of mTOR\/p70S6K pathway in esophageal squamous cell carcinoma","volume":"32","author":"Gong","year":"2015","journal-title":"Med. Oncol."},{"issue":"21","key":"10.1016\/j.cellsig.2025.112310_bb0545","doi-asserted-by":"crossref","first-page":"7945","DOI":"10.1158\/1078-0432.CCR-05-0840","article-title":"Histone deacetylase inhibitor FK228 activates tumor suppressor Prdx1 with apoptosis induction in esophageal cancer cells","volume":"11","author":"Hoshino","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112310_bb0550","first-page":"3152","article-title":"PRDX-1 promotes cell proliferation and inhibits apoptosis of human gliomas via TNF-\u03b1\/NF-\u03baB pathway","volume":"9","author":"Liu","year":"2016","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112310_bb0555","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/MPA.0000000000000270","article-title":"Peroxiredoxin 1 promotes pancreatic cancer cell invasion by modulating p38 MAPK activity","volume":"44","author":"Taniuchi","year":"2015","journal-title":"Pancreas"},{"issue":"4","key":"10.1016\/j.cellsig.2025.112310_bb0560","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S0022-5347(05)00659-2","article-title":"Enhanced expression of peroxiredoxin I and VI correlates with development, recurrence and progression of human bladder cancer","volume":"175","author":"Quan","year":"2006","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112310_bb0565","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12014-023-09419-8","article-title":"Comparative proteomics analysis in different stages of urothelial bladder cancer for identification of potential biomarkers: highlighted role for antioxidant activity","volume":"20","author":"Tabaei","year":"2023","journal-title":"Clin. Proteomics"},{"issue":"14","key":"10.1016\/j.cellsig.2025.112310_bb0570","doi-asserted-by":"crossref","first-page":"7136","DOI":"10.1158\/0008-5472.CAN-05-4446","article-title":"Prx1 suppresses radiation-induced c-Jun NH2-terminal kinase signaling in lung cancer cells through interaction with the glutathione S-transferase pi\/c-Jun NH2-terminal kinase complex","volume":"66","author":"Kim","year":"2006","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112310_bb0575","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ijrobp.2005.10.012","article-title":"Inhibition of lung tumor growth and augmentation of radiosensitivity by decreasing peroxiredoxin I expression","volume":"64","author":"Chen","year":"2006","journal-title":"Int. J. Radiat. Oncol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112310_bb0580","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3892\/ijo.2013.2208","article-title":"PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and-independent mechanisms","volume":"44","author":"Nicolussi","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cellsig.2025.112310_bb0585","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1124240","article-title":"Celastrol-regulated gut microbiota and bile acid metabolism alleviate hepatocellular carcinoma proliferation by regulating the interaction between FXR and RXR\u03b1 in vivo and in vitro","volume":"14","author":"Zeng","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112310_bb0590","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/biomedicines9050482","article-title":"Celastrol and triptolide suppress stemness in triple negative breast cancer: notch as a therapeutic target for stem cells","volume":"9","author":"Ramamoorthy","year":"2021","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112310_bb0595","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1021\/acscentsci.4c02188","article-title":"Discovery of natural resorcylic acid lactones as novel potent copper ionophores covalently targeting PRDX1 to induce cuproptosis for triple-negative breast cancer therapy","volume":"11","author":"Feng","year":"2025","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.cellsig.2025.112310_bb0600","article-title":"Glaucocalyxin A induces autophagy-mediated ferroptosis by targeting PRDX1 and TXNRD1 proteins in non-small cell lung cancer","author":"Wang","year":"2025","journal-title":"Phytomedicine"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825007259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825007259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:46:27Z","timestamp":1778762787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825007259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":120,"alternative-id":["S0898656825007259"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112310","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redox guardian or oncogenic driver? The dual roles of PRDX1 in tumorigenesis","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112310","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112310"}}